Aaron I. Davis, Director, 10% Owner at Odonate Therapeutics, Inc. (ODT), bought 125,000 shares at $13.46 ($1.7M) on 2018-12-21, disclosed to the SEC on 2018-12-27.
Open-market purchase of $1.7M ODT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.46 | 25,000 | $337K | 20.3% |
| 2 | $13.47 | 75,000 | $1.0M | 60.9% |
| 3 | $12.47 | 25,000 | $312K | 18.8% |
| Total | $13.27 avg | 125,000 | $1.7M | 100% |
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| RAIN | BUY | 2022-11-08 | $11.3M | — | Filing → |
| ITOS | SELL | 2022-05-11 | $20.2M | — | Filing → |